The use of plasma measure of sCD14 and SELL to distinguish ATB from HD reached respective sensitivity of 97% [95% CI 85–99] and specificity of 96% [95% CI 80–10] for sCD14 and a sensitivity of 97% [95% CI 86–99], specificity of 100% [95% CI 85–100] for SELL (Fig. 2C). This evidence concerns the gene SELL and Huntington disease.